The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
Seppic (La Garenne Colombes, France) has acquired EPI France, strengthening its position in the nutricosmetic market. EPI France’s flagship ingredient, Ceramosides, clinically validated to support skin both orally and topically, has been distributed by Seppic for over ten years. The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
“This acquisition opens up new growth opportunities for Seppic in the cosmetics and dietary supplements markets. We are very pleased to welcome EPI France teams to Seppic,” said Jean Baptiste Dellon, CEO of Seppic, in a press release. “Our long-standing relationship and the values of expertise, quality and customer care that we share with EPI France will allow us to quickly realize synergies for the development and marketing of new ingredients.”
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.